Ben Lam
About Ben Lam
Ben Lam serves as the Director of Flow Cytometry in Analytical Development at Sana Biotechnology, Inc. He has extensive experience in the field, having previously held positions at Fluidigm Corporation, Sangamo Therapeutics, and STEMCELL Technologies.
Current Role at Sana Biotechnology
Ben Lam serves as the Director of Flow Cytometry in the Analytical Development department at Sana Biotechnology, Inc. He has held this position since 2021, contributing to advancements in flow cytometry techniques and methodologies. His role involves overseeing analytical development processes and leading projects that enhance the company's capabilities in this area. He is based in South San Francisco, California.
Previous Experience in Flow Cytometry and Analytical Development
Before his current role, Ben Lam worked at Sana Biotechnology, Inc. as a Senior Scientist and Flow Cytometry Lead from 2019 to 2021. He also served as a Principal Scientist in Analytical Development for a brief period in 2021. His earlier experience includes positions at Fluidigm Corporation and Sangamo Therapeutics, where he focused on analytical method development and flow cytometry applications.
Career Background in Scientific Research
Ben Lam has a diverse background in scientific research, having worked at several prominent organizations. He began his career at STEMCELL Technologies as a Scientist from 2012 to 2016. He then transitioned to Fluidigm Corporation, where he held multiple roles, including Scientist I and Scientist II, from 2016 to 2019. His experience spans various aspects of analytical development and flow cytometry.
Educational Qualifications
Ben Lam holds a Bachelor of Science with Honors in Bioengineering from the University of California, Berkeley. He furthered his education by obtaining a Ph.D. in Genetics, Molecular, and Cellular Biology from the University of Southern California. His educational background provides a strong foundation for his work in analytical development and flow cytometry.